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2ABSTRACT
Wolbachia pipientis are obligate endosymbionts that infect a wide range of insect and other 
arthropod species. They act as reproductive parasites by manipulating the host reproduction 
machinery to enhance their own transmission. This unusual phenotype is thought to be a 
consequence of the actions of secreted Wolbachia proteins that are likely to contain disulfide 
bonds to stabilize the protein structure. In bacteria, the introduction or isomerization of 
disulfide bonds in proteins is catalysed by Dsb proteins. The Wolbachia genome encodes two 
proteins, -DsbA1 and -DsbA2, that might catalyse these steps. In this work we focussed 
on the 234-residue protein -DsbA1; the gene was cloned and expressed in E. coli, the 
protein was purified and its identity confirmed by mass spectrometry. The sequence identity 
of -DsbA1 is similar to that for both dithiol oxidants (Escherichia coli DsbA, 12%) and 
disulfide isomerases (E coli DsbC, 14%). We therefore sought to establish whether -DsbA1 
is an oxidant or an isomerase based on functional activity. The purified -DsbA1 was active 
in an oxidoreductase assay but had little isomerase activity, indicating that -DsbA1 is 
DsbA-like rather than DsbC-like. This work represents the first successful example of the 
characterization of a recombinant Wolbachia protein. Purified -DsbA1 will now be used in 
further functional studies to identify protein substrates that could help explain the molecular 
basis for the unusual Wolbachia phenotypes, and in structural studies to explore its 
relationship to other disulfide oxidoreductase proteins.
3INTRODUCTION
Disulfide bond formation is a crucial yet rate limiting step in protein folding [1, 2]. All 
organisms, ranging from bacteria to humans, encode catalysts that introduce disulfides into 
secreted proteins and membrane proteins [3]. In eukaryotes, protein folding occurs in the 
endoplasmic reticulum and disulfide formation is catalysed there, primarily by PDI [4]. For 
most prokaryotes, the introduction of disulfide bridges occurs in the periplasm and requires 
proteins of the Dsb (disulfide bond) family [5] that have disulfide/dithiol redox active sites.
Escherichia coli encodes at least six Dsb family members (DsbA, B, C, D, E and G). These 
proteins catalyze the oxidation (introduction) of disulfide bridges, isomerization (shuffling) 
of incorrectly introduced disulfide bonds and reduction (removal) of inappropriate disulfide 
bonds [2, 3, 6]. The oxidative pathway involves two proteins, DsbA and DsbB [3, 7, 8]. DsbB 
is an inner membrane protein that generates disulfide bonds de novo, and transfers these to 
the key oxidant DsbA. DsbA then introduces disulfide bonds indiscriminately into newly 
synthesized proteins via a thiol-disulfide exchange reaction. As a consequence, DsbA 
becomes reduced and must be reoxidized by DsbB. The isomerase pathway of DsbC/DsbG-
DsbD isomerizes disulfides that are incorrectly introduced by DsbA [9]. The isomerization is 
catalyzed by DsbC and DsbG, and these two proteins are maintained in an active dithiol 
(reduced) form through their interaction with the membrane protein DsbD [3, 8]. Finally, 
DsbE (CcmG) is a specialized disulfide reductant in the cytochrome c maturation pathway 
[10].
Dsb homologues are encoded in bacteria other than E. coli, and are important for 
pathogenicity because they help to fold secreted toxins and virulence factors [11, 12]. 
However, studies on Mycobacterium tuberculosis DsbE suggest that extrapolation of the role 
of Dsb proteins from the E. coli model may not be appropriate [13]. Moreover, some bacteria 
encode Dsb “hybrid” proteins that have features characteristic of both E. coli disulfide 
4oxidants and E. coli disulfide isomerases. These findings raise questions regarding the 
conservation of the Dsb pathway in other organisms and the role of Dsb hybrid proteins. 
We are interested in the Dsb pathway in the bacterium Wolbachia pipientis, a very common 
and widely distributed Gram-negative obligate intracellular symbiont. Wolbachia is estimated 
to infect 15-75% of all insects and a wide range of other arthropods and filarial nematodes 
[14-16]. A characteristic feature of this bacterium is its ability to manipulate its host’s 
reproduction by inducing a series of phenotypes (cytoplasmic incompatibility, feminization, 
male killing and parthenogenesis among others) that favour infected female reproduction, 
thus enhancing its own maternal transmission [17]. In filarial nematodes, Wolbachia is a 
mutualist, in that treatment of Wolbachia infection with antibiotics leads to developmental 
arrest and death of the host nematode [18]. Consequently, Wolbachia is a target for 
therapeutic intervention to combat filariasis [19] and may represent a useful biocontrol agent 
for insect pests and vector-borne parasites [20]. 
Little is known about the molecular mechanisms mediating the reproductive phenotypes 
induced by Wolbachia or its symbiotic interaction with host cells, though both are thought to 
involve secreted proteins, which need to be folded correctly to be functional. We have 
therefore focused our studies on the identification, expression and purification of Wolbachia
Dsb proteins, that may be important for the oxidative folding of secreted Wolbachia proteins 
and thus for inducing the phenotype and/or mediating communication between both partners 
in the association. Our analysis of the Wolbachia pipientis wMel genome [21] identified two 
DsbA-like homologues (WD1055 and WD1312) that we have named -DsbA1 and -
DsbA2, respectively. These two proteins share 21% sequence identity with each other. Here 
we describe the methods used to clone, express and purify -DsbA1 and its characterization 
as a DsbA. We plan to use the purified protein for structural and functional studies aimed at 
investigating the role of -DsbA1. 
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6MATERIALS AND METHODS
Cloning Wolbachia pipientis -DsbA1
Wolbachia pipientis wMel strain was maintained in Drosophila melanogaster yw67c23 flies 
reared on standard corn flour-sugar-yeast medium at 25ºC. Several flies were homogenized 
and Wolbachia DNA was extracted using an STE-PK extraction method [22]. Full-length 
Wolbachia -DsbA1 (locus WD1055 GenBank accession no AE017196) was amplified from 
wMel DNA by PCR using primers WDsbA1-Fwd1 (NdeI) (5’-
CCATATGATTTTTAGACTATTGTTTTTATTAATT-3’) and WDsbA1-Rev (XhoI) (5’-
CCTCGAGCTTCACTATAGCTTTTCC-3’). A gene lacking the 18-residue putative signal 
peptide was amplified using primers WDsbA1-Fwd2 (NdeI) (5’-
CCATATGAAGCAAGATTTATCCGATAA-3’) and WDsbA1-Rev. These primers replace 
the two residues immediately after the signal sequence with an ATG start codon (Met) and 
also introduce two additional residues (Leu-Glu) at the C-terminus. PCR cycling conditions 
were as follows: 95ºC 3 min, (95ºC 30 s, 52ºC 30s, 72ºC 10 min) x 35 cycles, then 72ºC for 
10 min. The reaction mixture contained 250 µM dNTPs, 500 nM of each primer, 1.5 mM 
MgCl2, 10-100 ng of DNA and 1 unit of Expand DNA Polymerase (Roche) in a final volume 
of 20 µl. PCR products were gel-purified using a QIAquick Gel Extraction Kit (Qiagen), A-
tailed and ligated into pGemT-easy (Promega) following standard protocols. The two 
constructs of Wolbachia -DsbA1 were digested from pGemT-easy using NdeI and XhoI, 
and ligated into these sites in pET42a (Novagen), adding a C-terminal octa-histidine tag to 
the coding sequence. Positive clones were identified by colony screening and then verified by 
sequencing using T7 promoter and T7 terminator primers at Macrogen (Korea). 
Protein Expression and Purification
7E. coli BL21(DE3)pLysS (Invitrogen) was transformed with the -dsbA1 constructs for 
protein expression. Large scale (2 L) expression was carried out at 30C for 24 h using 
autoinduction [23]. Cells were harvested and 100 ml lysis buffer (25 mM Tris-HCl pH 7, 150 
mM NaCl, 0.5% Triton-X, EDTA-free protease inhibitor cocktail (Roche) and DNase) was 
added per 1L pellet. To lyse the cells, the resuspended pellet was sonicated (Sonifier 250, 
Branson) three times for 2 min at constant duty cycle and an output energy of 80 W. The cell 
lysate was spun down and then incubated for 5 min at room temperature with PrepEase Ni2+
affinity resin (USB) (2 g per 100 ml  of lysate). The protein-bound resin was transferred to a 
column and washed extensively (at least 400 ml) with 50 mM Tris-HCl pH 7, 1 M NaCl, 20 
mM imidazole using gravity flow, until no protein could be detected in the flow-through. 
Bound -DsbA1 was eluted by adding at least 10 ml of 50 mM Tris-HCl pH 7, 150 mM 
NaCl, 250 mM imidazole to the column. Fractions of 1 ml were collected and tested for 
protein content using Protein Assay Dye (Biorad) before pooling for subsequent purification.
The protein was further purified by size exclusion chromatography (ÄKTAdesign, GE 
Healthcare), using a Superdex S200 or Superdex S75 column. The protein was eluted in 25 
mM HEPES-NaOH pH 7, 150 mM NaCl and concentrated for further experiments using ultra 
centrifugal devices (Amicon) with a 10,000 Da cut off. 
Protein concentration was determined spectrophotometrically by using a NanoDrop ND-1000 
(NanoDrop Technologies) and calculated from absorbance at 280 nm with the calculated 
molar absorption coefficient 280 = 26610 M-1 cm-1 or colorimetrically quantified by using the 
BCA Protein Assay Kit (Pierce). Purity was assessed by SDS-PAGE analysis and 
densitometry measurements using Quantity One 4.4 (Biorad). Briefly, after each purification 
step, aliquots were analysed by SDS-PAGE (NuPAGE novex Bis-tris gel, 4%-12% 
(Invitrogen)). Before loading, the samples were transferred into 2x loading dye [24] and 
denatured at 95˚C for 5 min. The gels were run in 1x NuPAGE MOPS SDS-running buffer 
8(Invitrogen, NP0001) at a constant voltage of 180 V for 50 min and visualized by staining 
with Coomassie Brilliant Blue (Sigma). The gels were scanned (SilverFast) and analyzed.
The amount of -DsbA1 at each purification step was estimated using densitometry of 
Coomassie stained SDS gels (see Methods). Total protein was quantified using the BCA 
protein assay with BSA as standard and 10 g was loaded onto each lane. The estimated 
yield in mg of -DsbA1 was calculated from the estimated amount of -DsbA1 in mg/ml and 
the total volume of sample at each step. Estimated yield (%) was calculated by comparison
with the amount of -DsbA1 in the lysate (=100%). Estimated purity at each step was 
calculated as the ratio of the estimated amount in mg/ml of -DsbA1 and total protein.
Circular dichroism 
Far-UV synchrotron radiation circular dichroism spectra (SRCD) for -DsbA1 were recorded 
at 4°C at station 12.1 of the Daresbury synchrotron radiation source, UK. The protein was at 
a concentration of 1.1 mg/ml in 50 mM Na Phosphate buffer pH 7.5 and 150 mM NaF. 
Measurements were made in triplicate in a 0.005 cm path length, quartz cuvette (Hellma). 
Curve fitting for secondary structure analysis was performed using Selcon3, ContinLL and 
CDSTTR algorithms available through the CDPro suite of software 
(http://lamar.colostate.edu/sreeram/CDPro/). The results of each algorithm were averaged.
High Performance Liquid Chromatography/Mass Spectrometry (HPLC/MS)
Purified -DsbA1 samples (1 mg/ml) in 50 mM HEPES pH 7, 150 mM NaCl buffer were 
analysed at the Mass Spectrometry Facility at the Institute for Molecular Bioscience, 
University of Queensland. For HPLC-ESI-MS analysis, samples were dissolved in 5% formic 
acid. Reverse phase HPLC was performed using a Phenomex 300A, C18 column with 0.1% 
9formic acid (solvent A) and 90% acetonitrile in 0.1% formic acid (solvent B). Solvent 
delivery and gradient formation was achieved using an Agilent 1100 binary solvent delivery 
system. Electrospray MS was performed using a Sciex QSTAR Pulsar/Quadropole time of 
flight mass spectrometer (Applied Biosystems). A full data scan was acquired at declustering 
and focussing potentials of 80 V and 280 V, respectively, over the mass range m/z 450-2000. 
Data collection and processing was carried out using Analyst QSi.
Sequence analysis
Sequence alignments and secondary structure predictions of E. coli DsbA (EcDsbA) and -
DsbA1 and E. coli DsbC (EcDsbC) and -DsbA1 were performed using the 3D-PSSM server  
[25]. Annotations of the alignments were performed in Adobe Illustrator. 
Biochemical studies
In vitro disulfide reductase activity of α-DsbA1 was measured by the ability of the protein to 
catalyse the reduction of insulin by DTT, as described previously [26]. The reaction mixtures 
were prepared fresh in 1 ml cuvettes by adding final concentrations of 0.13 mM insulin 
(Sigma), 0.33 mM DTT, 0.1 M sodium phosphate, 2 mM EDTA, pH 7 to various 
concentrations of the protein (4-10 M). The reduction of insulin was monitored by 
measuring the optical density of the samples at 650 nm for 80 min at 30 s intervals.
The ability of the protein to isomerize disulfide bonds was evaluated using the scrambled 
RNaseA (ScRNaseA) assay. Disulfide-scrambled RNaseA (Sigma) was produced using a 
modified protocol of [27].  Briefly, 70 mg of native RNaseA (four disulfide bonds) was 
incubated overnight at room temperature in 50 mM Tris-HCl, pH 8 in the presence of 6 M 
GdmCl and 150 mM DTT. The reduced, unfolded protein was acidified with 100 mM acetic 
acid/NaOH pH 4 and purified over a PD10 column. ScRNase concentration was determined 
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spectrophotometrically and the eight free thiol groups were verified using Ellman’s assay 
[28]. For random reoxidation, the reduced scRNase was diluted to a final concentration of 0.5 
mg/ml in 50 mM Tris-HCl, pH 8.5 and 6 M GdmCl and incubated in the dark at room 
temperature for at least three days. The randomly reoxidized RNase was concentrated, 
acidified and purified as described above. The oxidation of disulfide bonds was confirmed by 
using Ellman’s assay. Activity of α-DsbA1 was evaluated by measuring 
spectrophotometrically the renaturation of scRNaseA. Reactivated RNaseA regains native 
disulfide bridges and then can cleave cyclic-2’,3’-cytidinemonophosphate (cCMP) into 3’-
cytidinemonophosphate (3’CMP), resulting in an increase in absorption at 296 nm. 
Purified -DsbA1 (10 M) was added to 100 mM sodium phosphate, 1 mM EDTA, 10 M 
DTT pH 7 and preincubated for 5’ at 25C. To start the assay, 40 M scRNaseA was added. 
At several time points, 200 l aliquots were taken and added to 600 l of 4 mM cCMP (in 
100 mM sodium phosphate, 1 mM EDTA pH 7), so that the final assay volume was 800 l. 
The rate of RNaseA cleavage in the removed aliquots was then monitored 
spectrophotometrically at 296 nm for 2.5 min, and the fraction of native RNase (in %) was 
plotted against the incubation time.
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RESULTS 
Expression
We attempted expression of -DsbA1 in two ways, (1) by directing it to the cytoplasm 
through removal of the signal sequence and (2) by directing it to the periplasm with the 
native 18-residue N-terminal signal sequence. The cytoplasm-directed -DsbA1 was 
successfully expressed in a soluble form (Table 1) (Figure 1A). However, the periplasm-
directed -DsbA1 did not appear to be secreted; no -DsbA1 was detected in the periplasm 
but a low level of protein was detected by Western blot in the cytoplasmic pellet (not shown). 
We therefore concluded that -DsbA1 containing the Wolbachia pipientis signal sequence is 
not transported to the E coli periplasm. Because the cytoplasmic-directed protein expressed 
well, we focused further work on this soluble construct.
Purification
The initial purification step of -DsbA1 using immobilized metal affinity chromatography 
(IMAC) extracted 19 mg of 69 % pure protein from 1 L of culture (Table 1). High molecular 
mass contaminants were removed by size exclusion chromatography. This final purification 
step yielded 18 mg of homogeneous -DsbA1 from 1 L of culture (Figure 1).
Purified -DsbA1 was analysed by HPLC-ESI-MS to verify the molecular mass and identity. 
The analysis gave an experimental molecular mass of 26446.0 Da (Figure 2), in excellent 
agreement with the theoretical mass of 26446.5 or 26442.5 Da for reduced or oxidized 
truncated, C-terminally His-tagged -DsbA1. 
Is the protein a DsbA or a DsbC?
The sequence identity of -DsbA1 with EcDsbA (12%) and EcDsbC (14%) is similar, and it 
is therefore unclear from its sequence whether the protein is a dithiol oxidase or an 
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isomerase. We undertook structural and functional characterizations of the protein to address 
this question. SRCD analysis of purified -DsbA1 (Figure 3) indicates that native -DsbA1 
is folded and comprises 43% helix and 13% sheet. This secondary structure content compares 
well to the known helix and sheet content of EcDsbA (51% helix / 11% sheet) based on its 
crystal structure [29] but it is also close to that for EcDsbC (38% helix / 23% sheet) 
calculated from its crystal structure [30]. This result may reflect the fact that both DsbA and 
DsbC incorporate a thioredoxin fold. 
The fold recognition server 3D-PSSM [25] predicts a similar helical/sheet content for -
DsbA1 to that estimated from SRCD (Figure 4A). Furthermore, this analysis indicates that -
DsbA1 has the same overall fold as E. coli DsbA despite some differences at the N and C-
terminal segments. By comparison, 3D-PSSM comparison of -DsbA1 and EcDsbC (Figure 
4B) reveals a relatively poor alignment with several large gaps. A major difference between 
EcDsbA and EcDsbC, in structural terms, is that EcDsbA is a monomer whereas EcDsbC is a 
dimer due to an N-terminal (~60 residue) dimerization domain [30]. Notably, the predicted 
secondary structure at the N-terminus of -DsbA1 is very different to that of EcDsbC, 
indicating that it does not include a dimerization domain. This conclusion is supported by the 
fact that purified -DsbA1 is monomeric on the basis of its elution from a size exclusion 
chromatography column (data not shown). Overall, the secondary structure analysis, 
sequence comparison and oligomerization state suggests that, structurally, -DsbA1 is more 
DsbA-like than DsbC-like.
Biochemical Characterization
The sequence and secondary structure of α-DsbA1 suggests that it more closely resembles the 
dithiol oxidase EcDsbA than the disulfide isomerase EcDsbC. On the other hand, α-DsbA1 
includes residues that are commonly present in DsbC/G-type isomerases. For example, the 
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residue preceding the cis-Pro loop is generally a valine for DsbA, and a threonine for DsbC 
and DsbG isomerases (Figure 4B) yet α-DsbA1 also has a threonine in this position. To 
evaluate whether α-DsbA1 is functionally DsbA-like or DsbC-like we performed two assays 
that discriminate between these two activities. The insulin reduction assay is a general assay 
for oxidoreductase activity, and specifically probes disulfide reductase activity. As this assay 
relies on reducing activity, the oxidant EcDsbA has only about 10% the activity of the 
isomerase EcDsbC. We evaluated the activity of α-DsbA1 in this assay using EcDsbA and 
EcDsbC as controls.  The results (Figure 5) show that EcDsbC (4 M) rapidly reduces the 
disulfide bonds of insulin; disulfide reduction is detectable within 3 minutes and is complete 
in just over 20 min. A higher concentration of EcDsbA (10 M) yielded detectable insulin 
disulfide reduction after 19 min. α-DsbA1 (10 M) was a little less active again, with insulin 
reduction detectable after 22 min. Overall, the results of this assay indicate that α-DsbA1 is 
not a disulfide reductase, and is therefore more like the oxidant EcDsbA than the isomerase 
EcDsbC. 
We also performed a disulfide isomerase assay by evaluating the effect of α-DsbA1 to 
reactivate scrambled RNaseA (scRNaseA). To restore RNaseA activity, the oxidoreductase 
protein must isomerize the four randomly oxidized disulfide bonds of scRNaseA. Correctly 
disulfide-bonded RNaseA is active and can convert cCMP to 3’CMP, detectable by an 
increase in absorption at 296 nm. Inactive RNase has no activity in this assay. The positive 
control EcDsbC (10 µM), restored ~50% RNase activity within 60 min and ~80% activity 
after 8 h (Figure 6). By contrast, both EcDsbA and α-DsbA1 had a much lower ability to 
reactivate RNase, with just ~40% of native activity restored after 8 h (Figure 6). These results 
show that α-DsbA1 is functionally like DsbA.
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DISCUSSION
Over 50% of the Wolbachia pipientis wMel genome encodes proteins with at least two 
cysteines, and many of these would be expected to form disulfides. This situation suggests 
that a disulfide pathway must be encoded in Wolbachia to ensure rapid and accurate disulfide 
bond incorporation during protein folding. Wolbachia does encode Dsb family members, but 
whereas E. coli encodes at least 6 Dsb proteins, Wolbachia encodes just three: -DsbA1, -
DsbA2 and a DsbB-homologue. We focused on one of these three proteins, -DsbA1, and 
generated soluble recombinant Wolbachia -DsbA1 in milligram quantities from an E. coli
expression system. 
The primary sequence of -DsbA1 incorporates features that are characteristic of both 
oxidases (DsbA) and isomerases (DsbC). EcDsbA and EcDsbC both belong to the 
thioredoxin fold superfamily [31] and variations in the middle two residues of the CXXC 
active site motif are thought to give rise to variations in activity [3]. For example, the oxidant 
EcDsbA has CXHC and the isomerase EcDsbC has CXYC. Furthermore, the residue 
preceding the highly conserved cis-Pro loop of the thioredoxin fold is a valine in DsbAs and 
a threonine in DsbCs [32]. Surprisingly, the sequence of -DsbA1 incorporates features of 
both oxidases and isomerases; the active site motif is CYHC and the residue preceding the 
cis-Pro loop is a threonine rather than a valine. However, our secondary structure and 
sequence alignment analysis indicated that -DsbA1 is more like EcDsbA than EcDsbC.
We then investigated the oxidoreductase activity of -DsbA1 using the purified recombinant 
protein. We showed that -DsbA1 exhibits oxidoreductase activity in the insulin reductase 
activity, at about the same level of activity as EcDsbA. Furthermore, -DsbA1 has an activity 
similar to that of EcDsbA in the scRNase isomerase assay. In both assays, -DsbA1 is much 
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less active than EcDsbC. These results indicate that -DsbA1 is functionally more closely 
related to the oxidase EcDsbA than to the isomerase EcDsbC. 
In conclusion, this work describes the first functional characterisation of a Wolbachia protein, 
overexpressed and purified from E. coli. The purified protein, -DsbA1, is DsbA-like in 
secondary structure and activity, despite a low sequence homology. The methodology to 
produce purified and soluble -DsbA1 now enables structural studies as well as further 
functional analyses to help elucidate the role of this protein in the folding and secretion of 
proteins involved in the unusual Wolbachia phenotypes. We anticipate that the strategy we 
used to generate this recombinant Wolbachia protein for functional studies can also be 
applied to other Wolbachia targets.
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FIGURE LEGENDS
Figure 1
A. SDS-PAGE analysis of the purification of -DsbA1. Proteins were separated on NuPage 
novex 4%-12% SDS-PAGE gel (Invitrogen) and visualized by Coomassie staining. Lane 1: 
soluble fraction of cell lysate, lane 2: peak fraction after metal (Ni2+) chelate affinity 
chromatography, lane 3: peak fraction after size exclusion chromatography, lane 4: protein 
standard. 10 g of total protein (calculated using BCA protein assay kit) was loaded. 
Molecular mass standards (in kDa) are indicated at the right of the gel. Expressed -DsbA1 is 
indicated by a black box. B Lane 1: soluble fraction of cell lysate from BL21(DE3)pLysS 
with an -DsbA1 expression construct, the expressed protein is indicated by a black box, lane 
2: soluble fraction of untransformed BL21(DE3)pLysS cells, grown in expression media and 
lysed under the same conditions, lane 3: protein standard
Figure 2
HPLC-ESI-mass spectrum obtained from purified -DsbA1 showing the major peak at 
26446.0 Da (the calculated mass for reduced and oxidized is 26446.5 and 26442.5, 
respectively). Intensity is in counts per second (cps), and mass is in atomic mass units (amu). 
Figure 3
Far-UV SRCD spectra of oxidized -DsbA1.  The spectrum was recorded at 4C in a 0.005 
cm path length quartz cuvette containing 1.1 mg/ml protein in 50 mM Na phosphate buffer, 
pH 7.5. The calculated secondary structure of -DsbA1 is 43% -helix and 13% -sheet.
Figure 4
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Sequence alignment of the mature -DsbA1 and EcDsbA proteins (A) and EcDsbC (B) 
proteins. Secondary structure elements (predicted from sequence analysis for -DsbA1 using 
3D-PSSM or determined from the crystal structure for EcDsbA) are coloured in light grey
(helix) and dark grey (-sheet). Asterisks (*) denote identical residues. In the -DsbA1 
construct used herein, the two Val residues at the N-terminus are replaced with Met and 
additional residues are engineered at the C-terminus (Leu-Glu-His-His-His-His-His-His-His-
His). 
Figure 5
The oxidoreductase activity of -DsbA1 (10 M, ) is compared to that for the oxidase 
EcDsbA (10 µM, ), isomerase EcDsbC (4 M, ) and negative control (no catalyst, ). 
Reactions were performed in a final volume of 1 ml containing 0.13 mM insulin, 0.1 M 
sodium phosphate, 2 mM EDTA, pH 7 and purified protein. Reactions were started by adding 
DTT to a final concentration of 0.33 mM. Light scattering at 650 nm, caused by aggregation 
of reduced insulin, was recorded every 30 s for 80 min. -DsbA1 has a similar level of 
activity as EcDsbA.
Figure 6
Isomerase activity of -DsbA1 () was tested and compared to EcDsbA () and EcDsbC 
() by monitoring the catalysed reactivation of scrambled RNase (scRNase). Reactions 
contained 40 M scRNaseA in 100 mM sodium phospate/NaOH, pH 7.0, 1 mM EDTA, 10 
M DTT and 10 M protein. Folded RNase was used as a positive control (). The cleavage 
of cCMP by native/ reactivated RNase was followed spectrophotometrically at 296 nm. -
DsbA1 has a similar level of activity as EcDsbA.
.
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TABLE LEGEND
Table 1. Summary of the purification of recombinant -DsbA1
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Table 1. Summary of the purification of recombinant -DsbA1
Purification 
Step
Total 
Protein 
(mg/ml)
Total 
Volume 
(ml)
Estimated 
Amount 
of -
DsbA1 
(mg/ml)
Estimated
Yield of      
-DsbA1
(mg)
Estimated 
Yield of      
-DsbA1
(%)
Estimated 
Purity of      
-DsbA1
 (%)
Lysate 9.3 100 1.1 107 100 12
IMAC 3.5 8 2.4 19 18 69
Gel 
Filtration
3.8 4.8 3.8 18 17 100
Total protein was quantified using the BCA protein assay (Pierce) with BSA as 
standard. The amount of -DsbA1 was estimated from densitometric analysis of 
Coomassie stained SDS gels (see Methods). 
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